ReP USP - Resultado da busca

Artigo de periodico
Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity (2024)
Okazaki, Erica; Barion, Barbara Gomes; Rocha, Tania Rubia Flores da; Giacomo, Giovanna Di; Ho, Yeh-Li; Rothschild, Cynthia; Fatobene, Giancarlo; Moraes, Bruna del Guerra de Carvalho; Stefanello, Bianca; Rocha, Vanderson Geraldo
Source: Journal of thrombosis and thrombolysis. Unidade: FM
Subjects: COVID-19, TROMBOSE, COAGULAÇÃO SANGUÍNEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OKAZAKI, Erica et al. Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity. Journal of thrombosis and thrombolysis, v. 57, n. 4, p. 721-729, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76839. Acesso em: 21 out. 2025.
APA
Okazaki, E., Barion, B. G., Rocha, T. R. F. da, Giacomo, G. D., Ho, Y. -L., Rothschild, C., et al. (2024). Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity. Journal of thrombosis and thrombolysis, 57( 4), 721-729. doi:10.1007/s11239-024-02961-8
NLM
Okazaki E, Barion BG, Rocha TRF da, Giacomo GD, Ho Y-L, Rothschild C, Fatobene G, Moraes B del G de C, Stefanello B, Rocha VG. Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity [Internet]. Journal of thrombosis and thrombolysis. 2024 ; 57( 4): 721-729.[citado 2025 out. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76839
Vancouver
Okazaki E, Barion BG, Rocha TRF da, Giacomo GD, Ho Y-L, Rothschild C, Fatobene G, Moraes B del G de C, Stefanello B, Rocha VG. Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity [Internet]. Journal of thrombosis and thrombolysis. 2024 ; 57( 4): 721-729.[citado 2025 out. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76839
Artigo de periodico
Multiple myeloma and Chagas disease: qPCR as a marker forpreemptive antiparasitic therapy: a case reports series and review (2024)
Carvalho, Noemia Barbosa; Freitas, Vera Lucia Teixeira de ; Seguro, Fernanda Salles; Bezerra, Rita Cristina; Fatobene, Giancarlo; Nakanishi, erika Yoshie Shimoda; Visnadi, Helena; Rocha, Vanderson Geraldo ; Costa, Sílvia Figueiredo ; Yasuda, Maria Aparecida Shikanai
Source: Revista do Instituto de Medicina Tropical de São Paulo. Unidade: FM
Subjects: MIELOMA MÚLTIPLO, DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Noemia Barbosa et al. Multiple myeloma and Chagas disease: qPCR as a marker forpreemptive antiparasitic therapy: a case reports series and review. Revista do Instituto de Medicina Tropical de São Paulo, v. 66, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58769. Acesso em: 21 out. 2025.
APA
Carvalho, N. B., Freitas, V. L. T. de, Seguro, F. S., Bezerra, R. C., Fatobene, G., Nakanishi, erika Y. S., et al. (2024). Multiple myeloma and Chagas disease: qPCR as a marker forpreemptive antiparasitic therapy: a case reports series and review. Revista do Instituto de Medicina Tropical de São Paulo, 66. doi:10.1590/S1678-9946202466010
NLM
Carvalho NB, Freitas VLT de, Seguro FS, Bezerra RC, Fatobene G, Nakanishi erika YS, Visnadi H, Rocha VG, Costa SF, Yasuda MAS. Multiple myeloma and Chagas disease: qPCR as a marker forpreemptive antiparasitic therapy: a case reports series and review [Internet]. Revista do Instituto de Medicina Tropical de São Paulo. 2024 ; 66[citado 2025 out. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58769
Vancouver
Carvalho NB, Freitas VLT de, Seguro FS, Bezerra RC, Fatobene G, Nakanishi erika YS, Visnadi H, Rocha VG, Costa SF, Yasuda MAS. Multiple myeloma and Chagas disease: qPCR as a marker forpreemptive antiparasitic therapy: a case reports series and review [Internet]. Revista do Instituto de Medicina Tropical de São Paulo. 2024 ; 66[citado 2025 out. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58769
Artigo de periodico
Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America (2022)
Brandao, Antonio Adolfo Guerra Soares; Abdo, Andre Ramires Neder; Lage, Luis Alberto de Padua Covas; Fatobene, Giancarlo; Pereira, Juliana ; Rocha, Vanderson Geraldo
Source: Hematology. Unidade: FM
Subjects: NEOPLASIAS ÓSSEAS, SINAIS E SINTOMAS, BIÓPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANDAO, Antonio Adolfo Guerra Soares et al. Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America. Hematology, v. 27, n. 1, p. 65-69, 2022Tradução . . Disponível em: https://doi.org/10.1080/16078454.2021.2011547. Acesso em: 21 out. 2025.
APA
Brandao, A. A. G. S., Abdo, A. R. N., Lage, L. A. de P. C., Fatobene, G., Pereira, J., & Rocha, V. G. (2022). Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America. Hematology, 27( 1), 65-69. doi:10.1080/16078454.2021.2011547
NLM
Brandao AAGS, Abdo ARN, Lage LA de PC, Fatobene G, Pereira J, Rocha VG. Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America [Internet]. Hematology. 2022 ; 27( 1): 65-69.[citado 2025 out. 21 ] Available from: https://doi.org/10.1080/16078454.2021.2011547
Vancouver
Brandao AAGS, Abdo ARN, Lage LA de PC, Fatobene G, Pereira J, Rocha VG. Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America [Internet]. Hematology. 2022 ; 27( 1): 65-69.[citado 2025 out. 21 ] Available from: https://doi.org/10.1080/16078454.2021.2011547
Artigo de periodico
Telehealth in hematopoietic cell transplantation: perspective from patients at a public hospital in Brazil (2022)
Cordeiro, Ana ; Fatobene, Giancarlo; Mariano, Livia ; Rocha, Vanderson
Source: Bone marrow transplantation. Unidade: FM
Subjects: TRANSPLANTE DE MEDULA ÓSSEA, CÉLULAS-TRONCO, BRASILEIROS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORDEIRO, Ana et al. Telehealth in hematopoietic cell transplantation: perspective from patients at a public hospital in Brazil. Bone marrow transplantation, v. 57, n. 11, p. 1735-1736, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50427. Acesso em: 21 out. 2025.
APA
Cordeiro, A., Fatobene, G., Mariano, L., & Rocha, V. (2022). Telehealth in hematopoietic cell transplantation: perspective from patients at a public hospital in Brazil. Bone marrow transplantation, 57( 11), 1735-1736. doi:10.1038/s41409-022-01782-8
NLM
Cordeiro A, Fatobene G, Mariano L, Rocha V. Telehealth in hematopoietic cell transplantation: perspective from patients at a public hospital in Brazil [Internet]. Bone marrow transplantation. 2022 ; 57( 11): 1735-1736.[citado 2025 out. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50427
Vancouver
Cordeiro A, Fatobene G, Mariano L, Rocha V. Telehealth in hematopoietic cell transplantation: perspective from patients at a public hospital in Brazil [Internet]. Bone marrow transplantation. 2022 ; 57( 11): 1735-1736.[citado 2025 out. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50427
Artigo de periodico
Steroid-refractory chronic graft-versus-host disease: treatment options and patient management (2021)
Wolff, Daniel; Fatobene, Giancarlo; Rocha, Vanderson Geraldo ; Kroeger, Nicolaus; Flowers, Mary E
Source: Bone marrow transplantation. Unidade: FM
Subjects: DOENÇA CRÔNICA, DOENÇA ENXERTO-HOSPEDEIRO, CÉLULAS-TRONCO, QUALIDADE DE VIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WOLFF, Daniel et al. Steroid-refractory chronic graft-versus-host disease: treatment options and patient management. Bone marrow transplantation, v. 56, n. 9, p. 2079-2087, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41409-021-01389-5. Acesso em: 21 out. 2025.
APA
Wolff, D., Fatobene, G., Rocha, V. G., Kroeger, N., & Flowers, M. E. (2021). Steroid-refractory chronic graft-versus-host disease: treatment options and patient management. Bone marrow transplantation, 56( 9), 2079-2087. doi:10.1038/s41409-021-01389-5
NLM
Wolff D, Fatobene G, Rocha VG, Kroeger N, Flowers ME. Steroid-refractory chronic graft-versus-host disease: treatment options and patient management [Internet]. Bone marrow transplantation. 2021 ; 56( 9): 2079-2087.[citado 2025 out. 21 ] Available from: https://doi.org/10.1038/s41409-021-01389-5
Vancouver
Wolff D, Fatobene G, Rocha VG, Kroeger N, Flowers ME. Steroid-refractory chronic graft-versus-host disease: treatment options and patient management [Internet]. Bone marrow transplantation. 2021 ; 56( 9): 2079-2087.[citado 2025 out. 21 ] Available from: https://doi.org/10.1038/s41409-021-01389-5
Artigo de periodico
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR (2020)
Fatobene, Giancarlo; Rocha, Vanderson Geraldo ; Martin, Andrew St; Hamadani, Mehdi; Robinson, Stephen; Bashey, Asad; Boumendil, Ariane; Brunstein, Claudio; Castagna, Luca; Dominietto, Alida
Source: Journal of clinical oncology. Unidade: FM
Subjects: LEUCEMIA, TRANSPLANTE DE MEDULA ÓSSEA, SOBREVIDA, LINFOMA, PESQUISA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FATOBENE, Giancarlo et al. Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. Journal of clinical oncology, v. 38, n. 14, p. 1518-+, 2020Tradução . . Disponível em: https://doi.org/10.1200/JCO.19.02408. Acesso em: 21 out. 2025.
APA
Fatobene, G., Rocha, V. G., Martin, A. S., Hamadani, M., Robinson, S., Bashey, A., et al. (2020). Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. Journal of clinical oncology, 38( 14), 1518-+. doi:10.1200/JCO.19.02408
NLM
Fatobene G, Rocha VG, Martin AS, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C, Castagna L, Dominietto A. Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR [Internet]. Journal of clinical oncology. 2020 ; 38( 14): 1518-+.[citado 2025 out. 21 ] Available from: https://doi.org/10.1200/JCO.19.02408
Vancouver
Fatobene G, Rocha VG, Martin AS, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C, Castagna L, Dominietto A. Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR [Internet]. Journal of clinical oncology. 2020 ; 38( 14): 1518-+.[citado 2025 out. 21 ] Available from: https://doi.org/10.1200/JCO.19.02408
Artigo de periodico
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy (2019)
Solomon, Scott R; Martin, Andrew St; Shah, Nirav N; Fatobene, Giancarlo; Malki, Monzr M. Al; Ballen, Karen K; Bashey, Asad; Bejanyan, Nelli; Meade, Javier Bolanos; Rocha, Vanderson
Source: Blood advances. Unidade: FM
Subjects: TRANSPLANTE HOMÓLOGO, LINFÓCITOS T, LEUCEMIA MIELOIDE AGUDA, DOENÇAS DA MEDULA ÓSSEA, DOENÇA ENXERTO-HOSPEDEIRO, FÁRMACOS IMUNOSSUPRESSORES, CONDICIONAMENTO, SOBREVIVÊNCIA LIVRE DE DOENÇA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOLOMON, Scott R et al. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood advances, v. 3, n. 19, p. 2836-2844, 2019Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2019000627. Acesso em: 21 out. 2025.
APA
Solomon, S. R., Martin, A. S., Shah, N. N., Fatobene, G., Malki, M. M. A., Ballen, K. K., et al. (2019). Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood advances, 3( 19), 2836-2844. doi:10.1182/bloodadvances.2019000627
NLM
Solomon SR, Martin AS, Shah NN, Fatobene G, Malki MMA, Ballen KK, Bashey A, Bejanyan N, Meade JB, Rocha V. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy [Internet]. Blood advances. 2019 ; 3( 19): 2836-2844.[citado 2025 out. 21 ] Available from: https://doi.org/10.1182/bloodadvances.2019000627
Vancouver
Solomon SR, Martin AS, Shah NN, Fatobene G, Malki MMA, Ballen KK, Bashey A, Bejanyan N, Meade JB, Rocha V. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy [Internet]. Blood advances. 2019 ; 3( 19): 2836-2844.[citado 2025 out. 21 ] Available from: https://doi.org/10.1182/bloodadvances.2019000627
Artigo de periodico
The impact of pretransplant malnutrition on allogeneic hematopoietic stem cell transplantation outcomes (2019)
Hirose, Erika Yuri; Molla, Vinicius Campos de; Goncalves, Matheus Vescovi; Pereira, Andre Domingues; Szor, Roberta Shcolnik; Fonseca, Ana Rita Brito Medeiro da; Fatobene, Giancarlo; Serpa, Mariana Gomes; Xavier, Erick Menezes; Rocha, Vanderson Geraldo
Source: Clinical nutrition espen. Unidade: FM
Subjects: DESNUTRIÇÃO, CÉLULAS-TRONCO, DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE HOMÓLOGO, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIROSE, Erika Yuri et al. The impact of pretransplant malnutrition on allogeneic hematopoietic stem cell transplantation outcomes. Clinical nutrition espen, v. 33, p. 213-219, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.clnesp.2019.05.005. Acesso em: 21 out. 2025.
APA
Hirose, E. Y., Molla, V. C. de, Goncalves, M. V., Pereira, A. D., Szor, R. S., Fonseca, A. R. B. M. da, et al. (2019). The impact of pretransplant malnutrition on allogeneic hematopoietic stem cell transplantation outcomes. Clinical nutrition espen, 33, 213-219. doi:10.1016/j.clnesp.2019.05.005
NLM
Hirose EY, Molla VC de, Goncalves MV, Pereira AD, Szor RS, Fonseca ARBM da, Fatobene G, Serpa MG, Xavier EM, Rocha VG. The impact of pretransplant malnutrition on allogeneic hematopoietic stem cell transplantation outcomes [Internet]. Clinical nutrition espen. 2019 ; 33 213-219.[citado 2025 out. 21 ] Available from: https://doi.org/10.1016/j.clnesp.2019.05.005
Vancouver
Hirose EY, Molla VC de, Goncalves MV, Pereira AD, Szor RS, Fonseca ARBM da, Fatobene G, Serpa MG, Xavier EM, Rocha VG. The impact of pretransplant malnutrition on allogeneic hematopoietic stem cell transplantation outcomes [Internet]. Clinical nutrition espen. 2019 ; 33 213-219.[citado 2025 out. 21 ] Available from: https://doi.org/10.1016/j.clnesp.2019.05.005
Artigo de periodico-carta/editorial
Reassessment of risk factors and long-term results of autologous stem cell transplantation in relapsed and refractory classical Hodgkin lymphoma (2019)
Fatobene, Giancarlo; Linardi, Camila da Cruz Gouveia; Moreira, Frederico; Targueta, Gabriela Matos Falcao; Santos, Fernanda Maria; Velasques, Rodrigo Dolphini; Rocha, Vanderson Geraldo ; Buccheri, Valeria
Source: Hematological oncology. Unidade: FM
Subjects: FATORES DE RISCO, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, DOENÇA DE HODGKIN, RECIDIVA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FATOBENE, Giancarlo et al. Reassessment of risk factors and long-term results of autologous stem cell transplantation in relapsed and refractory classical Hodgkin lymphoma. Hematological oncology. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/hon.2604. Acesso em: 21 out. 2025. , 2019
APA
Fatobene, G., Linardi, C. da C. G., Moreira, F., Targueta, G. M. F., Santos, F. M., Velasques, R. D., et al. (2019). Reassessment of risk factors and long-term results of autologous stem cell transplantation in relapsed and refractory classical Hodgkin lymphoma. Hematological oncology. Hoboken: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/hon.2604
NLM
Fatobene G, Linardi C da CG, Moreira F, Targueta GMF, Santos FM, Velasques RD, Rocha VG, Buccheri V. Reassessment of risk factors and long-term results of autologous stem cell transplantation in relapsed and refractory classical Hodgkin lymphoma [Internet]. Hematological oncology. 2019 ; 37( 3): 310-313.[citado 2025 out. 21 ] Available from: https://doi.org/10.1002/hon.2604
Vancouver
Fatobene G, Linardi C da CG, Moreira F, Targueta GMF, Santos FM, Velasques RD, Rocha VG, Buccheri V. Reassessment of risk factors and long-term results of autologous stem cell transplantation in relapsed and refractory classical Hodgkin lymphoma [Internet]. Hematological oncology. 2019 ; 37( 3): 310-313.[citado 2025 out. 21 ] Available from: https://doi.org/10.1002/hon.2604
Artigo de periodico
BRAF V600E mutation detected in a case of Rosai-Dorfman disease (2018)
Fatobene, Giancarlo; Haroche, Julien; Helias-Rodzwicz, Zofia; Charlotte, Frederic; Taly, Valerie; Ferreira, Aliana Meneses; Abdo, Andre Neder Ramires; Rocha, Vanderson Geraldo; Emile, Jean-Francois
Source: Haematologica. Unidade: FM
Subjects: HISTIOCITOSE, IMUNOHISTOQUÍMICA, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FATOBENE, Giancarlo et al. BRAF V600E mutation detected in a case of Rosai-Dorfman disease. Haematologica, v. 103, n. 8, p. E377-E379, 2018Tradução . . Disponível em: https://doi.org/10.3324/haematol.2018.190934. Acesso em: 21 out. 2025.
APA
Fatobene, G., Haroche, J., Helias-Rodzwicz, Z., Charlotte, F., Taly, V., Ferreira, A. M., et al. (2018). BRAF V600E mutation detected in a case of Rosai-Dorfman disease. Haematologica, 103( 8), E377-E379. doi:10.3324/haematol.2018.190934
NLM
Fatobene G, Haroche J, Helias-Rodzwicz Z, Charlotte F, Taly V, Ferreira AM, Abdo ANR, Rocha VG, Emile J-F. BRAF V600E mutation detected in a case of Rosai-Dorfman disease [Internet]. Haematologica. 2018 ; 103( 8): E377-E379.[citado 2025 out. 21 ] Available from: https://doi.org/10.3324/haematol.2018.190934
Vancouver
Fatobene G, Haroche J, Helias-Rodzwicz Z, Charlotte F, Taly V, Ferreira AM, Abdo ANR, Rocha VG, Emile J-F. BRAF V600E mutation detected in a case of Rosai-Dorfman disease [Internet]. Haematologica. 2018 ; 103( 8): E377-E379.[citado 2025 out. 21 ] Available from: https://doi.org/10.3324/haematol.2018.190934
Artigo de periodico
Efeitos da anemia materna na cardiotocografia computadorizada e perfil biofísico fetal (2009)
Nomura, Roseli Mieko Yamamoto; Gordon, Marina Caldana; Fatobene, Giancarlo; Igai, Ana Maria Kondo; Zugaib, Marcelo
Source: Revista brasileira de ginecologia e obstetrícia. Unidade: FM
Subjects: GRAVIDEZ, ANEMIA (PREVENÇÃO E CONTROLE), SINAIS E SINTOMAS, DIAGNÓSTICO PRÉ-NATAL, FETO (CRESCIMENTO E DESENVOLVIMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOMURA, Roseli Mieko Yamamoto et al. Efeitos da anemia materna na cardiotocografia computadorizada e perfil biofísico fetal. Revista brasileira de ginecologia e obstetrícia, v. 31, n. 12, p. 615-620, 2009Tradução . . Disponível em: https://doi.org/10.1590/S0100-72032009001200007. Acesso em: 21 out. 2025.
APA
Nomura, R. M. Y., Gordon, M. C., Fatobene, G., Igai, A. M. K., & Zugaib, M. (2009). Efeitos da anemia materna na cardiotocografia computadorizada e perfil biofísico fetal. Revista brasileira de ginecologia e obstetrícia, 31( 12), 615-620. doi:10.1590/S0100-72032009001200007
NLM
Nomura RMY, Gordon MC, Fatobene G, Igai AMK, Zugaib M. Efeitos da anemia materna na cardiotocografia computadorizada e perfil biofísico fetal [Internet]. Revista brasileira de ginecologia e obstetrícia. 2009 ; 31( 12): 615-620.[citado 2025 out. 21 ] Available from: https://doi.org/10.1590/S0100-72032009001200007
Vancouver
Nomura RMY, Gordon MC, Fatobene G, Igai AMK, Zugaib M. Efeitos da anemia materna na cardiotocografia computadorizada e perfil biofísico fetal [Internet]. Revista brasileira de ginecologia e obstetrícia. 2009 ; 31( 12): 615-620.[citado 2025 out. 21 ] Available from: https://doi.org/10.1590/S0100-72032009001200007

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies